ProCredit Holding AG (ETR:PCZ)

ASLAN Pharmaceuticals Cash Flow Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	104.31	113.37	16.5	79.64	41.4
Depreciation & Amortization	20.76	18.35	23.79	18.02	19.59
Other Amortization	6.48	5.16	4.7	4.55	4.26
Gain (Loss) on Sale of Assets	-0.34	0.42	-0.2	0.1	0.8
Total Asset Writedown	-	0.38	1.91	1.4	0.99
Provision for Credit Losses	-6.11	13.45	104.09	6.71	28.68
Change in Other Net Operating Assets	-1,348	-610.27	-319.44	-641.81	-497.57
Other Operating Activities	13.42	14.01	-7.93	21.79	-30.48
Operating Cash Flow	-1,210	-445.13	-176.59	-509.61	-432.35
Capital Expenditures	-41.03	-27.85	-21.22	-17.49	-29.23
Sale of Property, Plant and Equipment	5.05	5.42	8.74	4.05	3.69
Other Investing Activities	-	0	-0	-	-0
Investing Cash Flow	-35.98	-22.42	-12.48	-13.44	-25.54
Long-Term Debt Issued	128	45.46	4	-	-
Long-Term Debt Repaid	-35.46	-7.89	-5.3	-4.79	-7.63
Net Debt Issued (Repaid)	92.54	37.57	-1.3	-4.79	-7.63
Common Dividends Paid	-37.7	-	-	-31.22	-
Net Increase (Decrease) in Deposit Accounts	1,033	969.18	743.53	642.75	568.23
Other Financing Activities	-	-	-	-	-8.81
Financing Cash Flow	1,088	1,007	742.22	606.75	551.8
Foreign Exchange Rate Adjustments	7.81	-9.56	5.99	35.87	-43.76
Net Cash Flow	-150.07	529.65	559.14	119.56	50.15
Free Cash Flow	-1,251	-472.98	-197.81	-527.1	-461.58
Free Cash Flow Margin	-277.25%	-118.42%	-82.82%	-187.92%	-203.93%
Free Cash Flow Per Share	-21.24	-8.03	-3.36	-8.95	-7.84
Cash Interest Paid	227.79	194.31	117.8	88.52	97.44
Cash Income Tax Paid	47.19	17.84	12.9	10.64	13.12

Updated Nov 19, 2024. Source: S&P Global Market Intelligence. Banks template. Financial Sources.